As of April 2025 KOBAYASHI Pharmaceutical has a market cap of HK$21.22 Billion. This makes KOBAYASHI Pharmaceutical the world's 3530th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | HK$21.22 B | -8.38% |
2024 | HK$23.17 B | -16.97% |
2023 | HK$27.90 B | -30.42% |
2022 | HK$40.10 B | -15.79% |
2021 | HK$47.62 B | -35.73% |
2020 | HK$74.09 B | 42.96% |
2019 | HK$51.83 B | 23.63% |
2018 | HK$41.92 B | 4.88% |
2017 | HK$39.97 B | 44.96% |
2016 | HK$27.57 B | 5.46% |
2015 | HK$26.14 B | 39.7% |
2014 | HK$18.71 B | 5.38% |
2013 | HK$17.76 B | 17.33% |
2012 | HK$15.13 B | -8.73% |
2011 | HK$16.58 B | 12.5% |
2010 | HK$14.74 B | 15.99% |
2009 | HK$12.71 B | -8.68% |
2008 | HK$13.92 B | 12.14% |
2007 | HK$12.41 B | 3.58% |
2006 | HK$11.98 B |
On Apr 5th, 2025 the market cap of KOBAYASHI Pharmaceutical was reported to be: